Watch the highlights of CSF Course Director, Joel Schlessinger, MD‘s Q & A session with the “Skin Cancer Epidemic: Mohs Update” panelists on some of the controversies related to skin cancer treatments: the expansion of XRT and the increasing number of biopsies by non-dermatologists.
Skin Cancer Epidemic: Mohs Updatecontroversies in Skin Cancer Treatmentsincreasing number of biopsies by non-dematologistsuse of XRT in private practiceAAD physician statementbiopsy ten or more lesionsprioritizing biopsy sites and treatCosmeticsENTOculoplasticCME Accreditationmedicaltraditional dermatologypracticalhonestinsightfuldiscussion basedbiopsiescosmetic surgeryCosmetic Surgery ForumdermatologyfeatureJoel SchlessingerM. Laurin Councilmohsmohs surgeryMurad AlamPlastic SurgeryQ&ARhett Druggeskin cancerskin cancer treatmentsXRT
CBD and Cosmetics: Does CBD really work?
- January 14, 2020
What Does Your Website Say About Your Practice?
- November 12, 2019
Does Creativity in Aesthetic Medicine Matter?
- October 8, 2019
Treating Skin of Color: Covering the Scale from I-IV
- August 28, 2019
Caring for Skin of Color Around the World: Part 1
- August 22, 2019